Clinical Trials Directory

Trials / Completed

CompletedNCT01950546

Nanosilver Fluoride to Prevent Dental Biofilms Growth

Nanosilver Fluoride: a Microbiological and Clinical Trial

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Pernambuco · Academic / Other
Sex
All
Age
5 Years – 6 Years
Healthy volunteers
Accepted

Summary

This study aims to evaluate the effectiveness of nanosilver fluoride for controlling the growth of S. mutans present in dental plaque of children.

Detailed description

The product will be apllied on cervical vestibular surfaces of incisors and canines healthy, with a total of 8 teeth, 4 upper and 4 below. Children will be instructed not to ingest any liquid or food within two hours after application. After a period of 7 days will be carried biofilm colect of cervical dental surfaces of incisors and / or canines upper and lower, with the aid of sterile spatulas. This material will be packaged in pre-weighed microfuge tubes containing 1.5 ml of buffered saline solution (0.9% sodium chloride), and transported under refrigeration immediately to the laboratory where analysis will be performed and the S. mutans colonies will be counted. The biofilm collect and posterior laboratorial analysis will be performed weekly.

Conditions

Interventions

TypeNameDescription
DRUGnanosilver fluorideThe product will be applied in the volunteers in the morning, before the first class, in relative isolation, made with cotton rolls and Vaseline to protect the soft tissue. It will apply 30mg of the product with microbrush, previously standardized in a pilot study on cervical vestibular surfaces of incisors and canines healthy, on a total of 8 teeth, 4 upper and 4 lower. After a period of 7 days,the cervical dental biofilms will be collect, third on the buccal surfaces of incisors and / or canines upper and lower, with the aid of sterile spatulas.

Timeline

Start date
2014-09-01
Primary completion
2014-12-01
Completion
2015-01-01
First posted
2013-09-25
Last updated
2015-06-10

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01950546. Inclusion in this directory is not an endorsement.